Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
16.86
-0.26 (-1.52%)
At close: Jun 27, 2025, 4:00 PM
17.35
+0.49 (2.91%)
After-hours: Jun 27, 2025, 7:21 PM EDT
Simulations Plus Employees
As of August 31, 2024, Simulations Plus had 247 total employees, including 243 full-time and 4 part-time employees. The number of employees increased by 50 or 25.38% compared to the previous year.
Employees
247
Change (1Y)
50
Growth (1Y)
25.38%
Revenue / Employee
$318,073
Profits / Employee
$29,393
Market Cap
339.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SLP News
- 10 days ago - Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call - Business Wire
- 15 days ago - Simulations Plus: Further Downside Is Likely (Rating Downgrade) - Seeking Alpha
- 16 days ago - Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt - Benzinga
- 16 days ago - Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum - Business Wire
- 17 days ago - Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue - Business Wire
- 23 days ago - Simulations Plus Releases ADMET Predictor® 13 - Business Wire
- 6 weeks ago - Simulations Plus Releases DILIsym® 11 - Business Wire
- 2 months ago - Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies - Business Wire